Alison Motsinger-Reif
Alison Motsinger-Reif
National Institute of Environmental Health Sciences
Verified email at nih.gov
Title
Cited by
Cited by
Year
Estimation of the warfarin dose with clinical and pharmacogenetic data
TE Klein, RB Altman, N Eriksson, BF Gage, SE Kimmel, MT Lee, NA Limdi, ...
The New England journal of medicine 360 (8), 753, 2009
14862009
A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction
DR Velez, BC White, AA Motsinger, WS Bush, MD Ritchie, SM Williams, ...
Genetic Epidemiology: the Official Publication of the International Genetic …, 2007
3582007
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups
NA Limdi, M Wadelius, L Cavallari, N Eriksson, DC Crawford, MTM Lee, ...
Blood, The Journal of the American Society of Hematology 115 (18), 3827-3834, 2010
3322010
CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection
A Motsinger, DW Haas, AK Stanic, L Van Kaer, S Joyce, D Unutmaz
The Journal of experimental medicine 195 (7), 869-879, 2002
2592002
Auriculotherapy for pain management: a systematic review and meta-analysis of randomized controlled trials
GN Asher, DE Jonas, RR Coeytaux, AC Reilly, YL Loh, AA Motsinger-Reif, ...
The Journal of Alternative and Complementary Medicine 16 (10), 1097-1108, 2010
1672010
Shift work in nurses: contribution of phenotypes and genotypes to adaptation
KL Gamble, AA Motsinger-Reif, A Hida, HM Borsetti, SV Servick, ...
PloS one 6 (4), e18395, 2011
1492011
Multifactor dimensionality reduction: an analysis strategy for modelling and detecting gene-gene interactions in human genetics and pharmacogenomics studies
AA Motsinger, MD Ritchie
Human genomics 2 (5), 318, 2006
1492006
Effect of CYP2B6, ABCB1, and CYP3A5 Polymorphisms on Efavirenz Pharmacokinetics and Treatment Response: An AIDS Clinical Trials Group Study
HJ Ribaudo, H Liu, M Schwab, E Schaeffeler, M Eichelbaum, ...
The Journal of infectious diseases 202 (5), 717-722, 2010
1432010
Genome-wide association studies in pharmacogenomics: successes and lessons
AA Motsinger-Reif, E Jorgenson, MV Relling, DL Kroetz, R Weinshilboum, ...
Pharmacogenetics and genomics 23 (8), 383, 2013
1272013
Metabolic network failures in Alzheimer's disease: A biochemical road map
JB Toledo, M Arnold, G Kastenmüller, R Chang, RA Baillie, X Han, ...
Alzheimer's & Dementia 13 (9), 965-984, 2017
1182017
Alterations in metabolic pathways and networks in Alzheimer’s disease
R Kaddurah-Daouk, H Zhu, S Sharma, M Bogdanov, SG Rozen, ...
Translational psychiatry 3 (4), e244-e244, 2013
1142013
Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity
MD Ritchie, DW Haas, AA Motsinger, JP Donahue, H Erdem, S Raffanti, ...
Clinical infectious diseases 43 (6), 779-782, 2006
1132006
Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation
D Darbar, AA Motsinger, MD Ritchie, JV Gainer, DM Roden
Heart Rhythm 4 (6), 743-749, 2007
1122007
Comparison of approaches for machine‐learning optimization of neural networks for detecting gene‐gene interactions in genetic epidemiology
AA Motsinger‐Reif, SM Dudek, LW Hahn, MD Ritchie
Genetic Epidemiology: The Official Publication of the International Genetic …, 2008
1052008
GPNN: Power studies and applications of a neural network method for detecting gene-gene interactions in studies of human disease
AA Motsinger, SL Lee, G Mellick, MD Ritchie
BMC bioinformatics 7 (1), 39, 2006
952006
Characterization of conserved and nonconserved imprinted genes in swine
SR Bischoff, S Tsai, N Hardison, AA Motsinger-Reif, BA Freking, ...
Biology of reproduction 81 (5), 906-920, 2009
942009
Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL
KL Richards, AA Motsinger-Reif, HW Chen, Y Fedoriw, C Fan, ...
Cancer research 73 (16), 5029-5039, 2013
922013
CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel
DL Hertz, S Roy, AA Motsinger-Reif, A Drobish, LS Clark, HL McLeod, ...
Annals of oncology 24 (6), 1472-1478, 2013
922013
CYP2C8* 3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel
DL Hertz, AA Motsinger-Reif, A Drobish, SJ Winham, HL McLeod, ...
Breast cancer research and treatment 134 (1), 401-410, 2012
892012
Multifactor dimensionality reduction for detecting gene–gene and gene–environment interactions in pharmacogenomics studies
MD Ritchie, AA Motsinger
Future Medicine Ltd 6 (8), 823-834, 2005
882005
The system can't perform the operation now. Try again later.
Articles 1–20